These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

271 related articles for article (PubMed ID: 32456080)

  • 1. Synthetic Strategies and Computational Inhibition Activity Study for Triazinyl-Substituted Benzenesulfonamide Conjugates with Polar and Hydrophobic Amino Acids as Inhibitors of Carbonic Anhydrases.
    Mikulová MB; Kružlicová D; Pecher D; Supuran CT; Mikuš P
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32456080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and Inhibition Activity Study of Triazinyl-Substituted Amino(alkyl)-benzenesulfonamide Conjugates with Polar and Hydrophobic Amino Acids as Inhibitors of Human Carbonic Anhydrases I, II, IV, IX, and XII.
    Mikulová MB; Kružlicová D; Pecher D; Petreni A; Supuran CT; Mikuš P
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel sulfonamides incorporating 1,3,5-triazine and amino acid structural motifs as inhibitors of the physiological carbonic anhydrase isozymes I, II and IV and tumor-associated isozyme IX.
    Mikuš P; Krajčiová D; Mikulová M; Horváth B; Pecher D; Garaj V; Bua S; Angeli A; Supuran CT
    Bioorg Chem; 2018 Dec; 81():241-252. PubMed ID: 30153589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX.
    Garaj V; Puccetti L; Fasolis G; Winum JY; Montero JL; Scozzafava A; Vullo D; Innocenti A; Supuran CT
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3102-8. PubMed ID: 15905091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides incorporating 1,2,4-triazine moieties.
    Garaj V; Puccetti L; Fasolis G; Winum JY; Montero JL; Scozzafava A; Vullo D; Innocenti A; Supuran CT
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5427-33. PubMed ID: 15454239
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Substituted benzene sulfonamides incorporating 1,3,5-triazinyl moieties potently inhibit human carbonic anhydrases II, IX and XII.
    Saluja AK; Tiwari M; Vullo D; Supuran CT
    Bioorg Med Chem Lett; 2014 Mar; 24(5):1310-4. PubMed ID: 24507918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel sulfonamide incorporating piperazine, aminoalcohol and 1,3,5-triazine structural motifs with carbonic anhydrase I, II and IX inhibitory action.
    Havránková E; Csöllei J; Vullo D; Garaj V; Pazdera P; Supuran CT
    Bioorg Chem; 2018 Apr; 77():25-37. PubMed ID: 29324250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with Schiff's bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes.
    Puccetti L; Fasolis G; Vullo D; Chohan ZH; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3096-101. PubMed ID: 15908204
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human carbonic anhydrase isozymes I, II, IX and XII with a new series of sulfonamides incorporating aroylhydrazone-, [1,2,4]triazolo[3,4-b][1,3,4]thiadiazinyl- or 2-(cyanophenylmethylene)-1,3,4-thiadiazol-3(2H)-yl moieties.
    Alafeefy AM; Abdel-Aziz HA; Vullo D; Al-Tamimi AM; Awaad AS; Mohamed MA; Capasso C; Supuran CT
    J Enzyme Inhib Med Chem; 2015 Feb; 30(1):52-6. PubMed ID: 24666294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural study of the location of the phenyl tail of benzene sulfonamides and the effect on human carbonic anhydrase inhibition.
    Güzel-Akdemir O; Biswas S; Lastra K; McKenna R; Supuran CT
    Bioorg Med Chem; 2013 Nov; 21(21):6674-80. PubMed ID: 24012377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 5-Substituted-(1,2,3-triazol-4-yl)thiophene-2-sulfonamides strongly inhibit human carbonic anhydrases I, II, IX and XII: solution and X-ray crystallographic studies.
    Leitans J; Sprudza A; Tanc M; Vozny I; Zalubovskis R; Tars K; Supuran CT
    Bioorg Med Chem; 2013 Sep; 21(17):5130-8. PubMed ID: 23859774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carbonic anhydrase inhibitors: synthesis and inhibition of the human carbonic anhydrase isoforms I, II, VII, IX and XII with benzene sulfonamides incorporating 4,5,6,7-tetrabromophthalimide moiety.
    Sethi KK; Vullo D; Verma SM; Tanç M; Carta F; Supuran CT
    Bioorg Med Chem; 2013 Oct; 21(19):5973-82. PubMed ID: 23965175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of new ureido benzenesulfonamides incorporating 1,3,5-triazine moieties as carbonic anhydrase I, II, IX and XII inhibitors.
    Lolak N; Akocak S; Bua S; Sanku RKK; Supuran CT
    Bioorg Med Chem; 2019 Apr; 27(8):1588-1594. PubMed ID: 30846402
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring new Probenecid-based carbonic anhydrase inhibitors: Synthesis, biological evaluation and docking studies.
    Mollica A; Costante R; Akdemir A; Carradori S; Stefanucci A; Macedonio G; Ceruso M; Supuran CT
    Bioorg Med Chem; 2015 Sep; 23(17):5311-8. PubMed ID: 26264840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of curcumin inspired sulfonamide derivatives as a new class of carbonic anhydrase isoforms I, II, IX, and XII inhibitors.
    Ramya PVS; Angapelly S; Angeli A; Digwal CS; Arifuddin M; Babu BN; Supuran CT; Kamal A
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1274-1281. PubMed ID: 28965419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbonic anhydrase inhibitors: synthesis and inhibition of the human carbonic anhydrase isoforms I, II, IX and XII with benzene sulfonamides incorporating 4- and 3-nitrophthalimide moieties.
    Sethi KK; Verma SM; Tanç M; Purper G; Calafato G; Carta F; Supuran CT
    Bioorg Med Chem; 2014 Mar; 22(5):1586-95. PubMed ID: 24513184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of 3,4-Dihydroisoquinoline-2(1H)-sulfonamides as potent carbonic anhydrase inhibitors: synthesis, biological evaluation, and enzyme--ligand X-ray studies.
    Gitto R; Agnello S; Ferro S; De Luca L; Vullo D; Brynda J; Mader P; Supuran CT; Chimirri A
    J Med Chem; 2010 Mar; 53(6):2401-8. PubMed ID: 20170095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New amide derivatives of Probenecid as selective inhibitors of carbonic anhydrase IX and XII: biological evaluation and molecular modelling studies.
    Carradori S; Mollica A; Ceruso M; D'Ascenzio M; De Monte C; Chimenti P; Sabia R; Akdemir A; Supuran CT
    Bioorg Med Chem; 2015 Jul; 23(13):2975-81. PubMed ID: 26007302
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N'-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.
    Żołnowska B; Sławiński J; Pogorzelska A; Chojnacki J; Vullo D; Supuran CT
    Eur J Med Chem; 2014 Jan; 71():135-47. PubMed ID: 24291567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superacid synthesis of halogen containing N-substituted-4-aminobenzene sulfonamides: new selective tumor-associated carbonic anhydrase inhibitors.
    Compain G; Martin-Mingot A; Maresca A; Thibaudeau S; Supuran CT
    Bioorg Med Chem; 2013 Mar; 21(6):1555-63. PubMed ID: 22705188
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.